Tag Archives: ADHD

FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD

FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD Print this page STAMFORD, Conn.–(BUSINESS WIRE) March 01, 2019 –Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII, a central nervous system (CNS) stimulant, for… Read More »

Could Young Age at School Start Lead to False Diagnosis of ADHD?

Print this page WEDNESDAY, Nov. 28, 2018 — Does being the youngest in the class up your child’s odds of being erroneously diagnosed with attention deficit hyperactivity disorder (ADHD)? It might. New research suggests these kids appear to be about 30 percent more likely to receive a diagnosis of ADHD. However, it probably doesn’t change… Read More »